Home » Topics » Regulatory

Regulatory
RSS

Ranexa approved for chronic angina

Jan. 30, 2006

Exubera approved in Europe and the U.S.

Jan. 30, 2006

Sutent approved for advanced renal cell carcinoma and malignant GIST

Jan. 30, 2006

Japanese approval for Urief

Jan. 24, 2006

FDA approval for subcutaneous immunoglobulin treatment Vivaglobin

Jan. 11, 2006

Climara Pro approved for prevention of postmenopausal osteoporosis

Jan. 9, 2006

FDA approval for Vaprisol in euvolemic hyponatremia

Jan. 2, 2006

Femara receives new U.S. approval

Dec. 30, 2005

Revlimid receives FDA approval

Dec. 29, 2005

Orencia approved for rheumatoid arthritis

Dec. 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...